Clinical Trials

A Phase II, Randomized, Open-label Platform Study of Novel Regimens Versus Standard of Care Treatment in NSCLC Participants


Study ID
GlaxoSmithKline 205801

NCT Number
NCT03739710 (Click on the NCT number for more information about the trial)

Research Study Number
2019-0093

Principle Investigator
Dr. Martin Gutierrez

Phase
II

Sponsor
GlaxoSmithKline


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now